Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PSMC4 promotes prostate carcinoma progression by regulating the CBX3-EGFR-PI3K-AKT-mTOR pathway. | J Cell Mol Med | 2023 | 37436074 | PubTator, text mining | PubMed |
| Dysfunction of ubiquitin protein ligase MYCBP2 leads to cell resilience in human breast cancers. | NAR Cancer | 2023 | 37435531 | PubTator, text mining | PubMed |
| Editorial: Epigenetic mechanisms and epigenetic-based therapies in cardiometabolic and vascular disease. | Front Genet | 2023 | 37424724 | PubTator, text mining | PubMed |
| Near atmospheric carbon dioxide activates plant ubiquitin cross-linking. | BBA Adv | 2023 | 37416898 | PubTator, text mining | PubMed |
| The ubiquitin-protein ligase MIEL1 localizes to peroxisomes to promote seedling oleosin degradation and lipid droplet mobilization. | Proc Natl Acad Sci U S A | 2023 | 37410814 | PubTator, text mining | PubMed |
| DNA repair pathways-targeted cyclovirobuxine inhibits castration-resistant prostate cancer growth by promoting cell apoptosis and cycle arrest. | Transl Oncol | 2023 | 37406549 | PubTator, text mining | PubMed |
| SnRNA-Seq analysis reveals ten hub genes associated with alveolar epithelial cell injury during pulmonary acute respiratory distress syndrome. | Heliyon | 2023 | 37389073 | PubTator, text mining | PubMed |
| Chronic obstructive pulmonary disease alters the genetic landscape and tumor immune microenvironment in lung cancer patients. | Front Oncol | 2023 | 37388220 | PubTator, text mining | PubMed |
| Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors. | Sci Rep | 2023 | 37386052 | PubTator, text mining | PubMed |
| Ring finger protein 215 is a potential prognostic biomarker involved in immune infiltration and angiogenesis in colorectal cancer. | Biomed Rep | 2023 | 37383678 | PubTator, text mining | PubMed |
| Challenges and Strategies for Developing Recombinant Vaccines against Leptospirosis: Role of Expression Platforms and Adjuvants in Achieving Protective Efficacy. | Pathogens | 2023 | 37375478 | PubTator, text mining | PubMed |
| The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. | Int J Mol Sci | 2023 | 37373484 | PubTator, text mining | PubMed |
| Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis. | Biomolecules | 2023 | 37371520 | PubTator, text mining | PubMed |
| A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer. | BMC Cancer | 2023 | 37370046 | PubTator, text mining | PubMed |
| Mitochondrial ROS and base excision repair steps leading to DNA nick formation drive ultraviolet induced-NETosis. | Front Immunol | 2023 | 37350954 | PubTator, text mining | PubMed |
| Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development. | Orphanet J Rare Dis | 2023 | 37349793 | PubTator, text mining | PubMed |
| Establishment of Risk Model and Analysis of Immunoinfiltration Based on Mitophagy-Related Associated Genes in Atrial Fibrillation. | J Inflamm Res | 2023 | 37346800 | PubTator, text mining | PubMed |
| Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology. | Inform Med Unlocked | 2023 | 37346467 | PubTator, text mining | PubMed |
| BeEM: fast and faithful conversion of mmCIF format structure files to PDB format. | BMC Bioinformatics | 2023 | 37340457 | PubTator, text mining | PubMed |
| Autistic spectrum disorder (ASD) - Gene, molecular and pathway signatures linking systemic inflammation, mitochondrial dysfunction, transsynaptic signalling, and neurodevelopment. | Brain Behav Immun Health | 2023 | 37334258 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=15